​(Communicated by the Israel Innovation Authority Spokesperson)

The 25th annual BIO International Convention will be held from June 4th-7th in Boston. The conference, considered the world’s largest and most prestigious biotechnology conference, will host 16,000 professionals from more than 74 countries, showcasing the best and most promising new companies and developments in medical technology and life sciences. Nine leading Israeli biotech companies will be participating.
 
“The conference is a dynamic and professional platform for the exchange of ideas, experiences, insights, and best practices pertaining to biotechnological innovation,” said Israeli Minister of Economy and Industry, Eli Cohen. “It is intended to provide solutions to some of the most pressing and important global challenges, such as: treatment of chronic illnesses, improving public health in the digital age, feeding growing populations and keeping up with global energy demand.”
 
“Israel will be represented at the conference by an impressive national pavilion which will include nine leading companies carefully selected by the Israel Innovation Authority, with support from the Israel Advanced Technology Industries (IATI). These companies represent Israeli innovation in various fields of the life sciences,” Cohen added.
 
EIMindA, amongst the companies representing Israel, has won international recognition for revolutionizing the field of brain technology by leveraging machine learning and IoT for analyzing brain function patterns. Other Israeli companies attending include: BiomX, a company developing microbe-based technologies and medicines for treating acute chronic illnesses such as cancer and obesity, and; Taliaz, a company that has developed an artificial-intelligence based smart platform helping physicians match anti-depressants to their patients according to specific genetic and health characteristics.
 
Aharon Aharon, CEO of the Israel Innovation Authority, which has participated in the conference for the past 20 years and facilitated the Israeli national pavilion for the past decade, said: “The Israel Innovation Authority’s goal is to increase support for a dynamic medical and pharmaceutical ecosystem, with the goal of positioning Israel as a global leader in these fields. The Authority aspires to bring significant multinational companies in the field to Israel and is pleased to offer several avenues of support for entrepreneurs, helping them maximize their potential. These include programs encouraging the establishment of R&D centers in biotechnology and medicine for multinational companies and startups, promoting technological infrastructure, providing financing and offering cooperation platforms supported by the Authority together with counterparts from 65 countries around the world.”
 
Israel Shamai, Head of the Americas Desk at the Israel Innovation Authority, noted: “The BIO International Convention is an important event and incredible opportunity for Israeli innovation in the health and biomedical industries. Companies that have taken part in this conference in the past have reported success in forging groundbreaking deals, funding, collaboration agreements, and ties with strategic partners that were the direct result of meetings held during the conference.”
 
The nine companies representing Israel in Boston this year are:

• BiomX
• Cell Cure Neurosciences LTD
• EIMindA
• FutuRx LTD
• Mitoconix
• Nucleix Ltd
• Pluristem Therapeutics Inc
• TALIAZ Ltd
• VBL Therapeutics